A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers
NCT01465139
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CDX-301
Sponsor
Celldex Therapeutics